Literature DB >> 27815481

Definitive Radiation Therapy for Angiosarcoma of the Face and Scalp.

Gen Suzuki1, Hideya Yamazaki2, Hideya Takenaka3, Norihiro Aibe2, Koji Masui2, Takuya Kimoto2, Kotoha Tatekawa2, Akihiro Nakashima2, Tadashi Takenaka2, Jun Asai3, Satoshi Komori3, Makoto Wada3, Norito Katoh3, Kei Yamada2.   

Abstract

AIM: To examine the role of radiation therapy (RT) and factors' influence on tumor control for angiosarcoma of the face and scalp (AS-FS). PATIENTS AND METHODS: We reviewed the records of 14 patients with histopathology proven AS-FS (median age=77 years) who underwent RT between 2000 and 2015. A total dose of 60 to 100 Gy was administered in 24 to 50 fractions. The median calculated biological effective dose (BED) was 93 Gy (range=63.25-120) based on α/β=10. The median follow-up was 16 months (range=5-62).
RESULTS: Of the 14 patients, 8 patients (57%) experienced disease recurrence. The median overall survival (OS) rate was 31 months. The 1-year actuarial OS, event-free survival (EFS) and local control (LC) rates were 83%, 71% and 71%, respectively. In univariate analysis, age ≥78years was a significant prognostic factor for LC and OS. BED ≥95Gy was highly correlated with increased LC with borderline significance (p=0.06).
CONCLUSION: Older patients had significantly lower survival rates and higher local recurrence rates than younger patients. The higher radiation dose may have a potential to improve local control for AS-FS.
Copyright © 2016 International Institute of Anticancer Research (Dr. John G. Delinassios), All rights reserved.

Entities:  

Keywords:  BED; Radiation therapy; age; angiosarcoma; prognostic factors

Mesh:

Year:  2016        PMID: 27815481     DOI: 10.21873/invivo.11014

Source DB:  PubMed          Journal:  In Vivo        ISSN: 0258-851X            Impact factor:   2.155


  7 in total

Review 1.  Angiosarcoma: a review of diagnosis and current treatment.

Authors:  Jun Cao; Jiale Wang; Chiyu He; Meiyu Fang
Journal:  Am J Cancer Res       Date:  2019-11-01       Impact factor: 6.166

2.  Single institutional experience of radiation therapy for angiosarcoma of the scalp without cervical lymph node metastases: Impact of concurrent chemoradiation with maintenance chemotherapy using taxanes on patient prognosis.

Authors:  Hiroki Ihara; Tatsuya Kaji; Kuniaki Katsui; Tomoko Miyake; Takahiro Waki; Norihisa Katayama; Hidenobu Matsuzaki; Osamu Yamasaki; Masahiro Kuroda; Shin Morizane; Susumu Kanazawa
Journal:  Mol Clin Oncol       Date:  2019-09-05

3.  Clinical Usefulness of the Platelet-to Lymphocyte Ratio in Patients with Angiosarcoma of the Face and Scalp.

Authors:  Gen Suzuki; Hideya Yamazaki; Norihiro Aibe; Koji Masui; Naomi Sasaki; Daisuke Shimizu; Takuya Kimoto; Jun Asai; Makoto Wada; Satoshi Komori; Norito Katoh; Kei Yamada
Journal:  Int J Mol Sci       Date:  2017-11-13       Impact factor: 5.923

4.  Novel strategy with the automatic non-coplanar volumetric-modulated arc therapy for angiosarcoma of the scalp.

Authors:  Shoki Inui; Yoshihiro Ueda; Shingo Ohira; Haruhi Tsuru; Masaru Isono; Masayoshi Miyazaki; Masahiko Koizumi; Teruki Teshima
Journal:  Radiat Oncol       Date:  2020-07-17       Impact factor: 3.481

5.  A successful approach for angiosarcoma of the scalp using helical tomotherapy and customized surface mold brachytherapy: A case report.

Authors:  Gen Suzuki; Koji Masui; Sho Watanabe; Hideya Yamazaki; Tadashi Takenaka; Jun Asai; Ayano Maruyama; Kei Yamada
Journal:  Medicine (Baltimore)       Date:  2021-12-10       Impact factor: 1.817

6.  Prognostic factor analysis of definitive radiotherapy using intensity-modulated radiation therapy and volumetric modulated arc therapy with boluses for scalp angiosarcomas.

Authors:  Tairo Kashihara; Hiroshi Igaki; Dai Ogata; Hiroki Nakayama; Satoshi Nakamura; Kae Okuma; Taisuke Mori; Kohei Yamakawa; Akira Takahashi; Kenjiro Namikawa; Ayaka Takahashi; Kana Takahashi; Tomoya Kaneda; Koji Inaba; Naoya Murakami; Yuko Nakayama; Hiroyuki Okamoto; Naoya Yamazaki; Jun Itami
Journal:  Sci Rep       Date:  2022-03-14       Impact factor: 4.379

Review 7.  Malignant Vascular Tumors of the Head and Neck-Which Type of Therapy Works Best?

Authors:  Susanne Wiegand; Andreas Dietz; Gunnar Wichmann
Journal:  Cancers (Basel)       Date:  2021-12-09       Impact factor: 6.639

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.